AMJ Dermatology 2 [Supplement 2] . 2025

In this issue

A new study highlights the potential of gene expression profiling (40-GEP) in improving risk prediction for patients with high-risk cutaneous squamous cell carcinoma (cSCC). By combining molecular data with established clinical staging systems, healthcare providers can better personalize treatment plans and surveillance strategies, ultimately enhancing patient outcomes.